Иммунитет | Ибн Сино тавсиялари
👋Hammaga Salom! Kanalimizga xush kelibsiz. Siz bizning kanalda👇 📊Forex haqida ma'lumotlar 📢Ishonchli signallar (97%) ⌨️Pul topishni yól ko'rsataman 📺Forex Olamdagi yangiliklarini 🕋Halol yól bilan topamiz pul Admin: @Zafar_FxDaromad
Show more📈 Analytical overview of Telegram channel Иммунитет | Ибн Сино тавсиялари
Channel Иммунитет | Ибн Сино тавсиялари in the Uzbek language segment is an active participant. Currently, the community unites 14 346 subscribers, ranking 1 751 in the Medicine category and 5 761 in the Uzbekistan region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 14 346 subscribers.
According to the latest data from 17 June, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -834 over the last 30 days and by -32 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 2.43%. Within the first 24 hours after publication, content typically collects 1.73% reactions from the total number of subscribers.
- Post reach: On average, each post receives 349 views. Within the first day, a publication typically gains 249 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 1.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“👋Hammaga Salom! Kanalimizga xush kelibsiz. Siz bizning kanalda👇
📊Forex haqida ma'lumotlar
📢Ishonchli signallar (97%)
⌨️Pul topishni yól ko'rsataman
📺Forex Olamdagi yangiliklarini
🕋Halol yól bilan topamiz pul
Admin: @Zafar_FxDaromad”
Thanks to the high frequency of updates (latest data received on 18 June, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
Available now! Telegram Research 2025 — the year's key insights 
